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Abstract: This manuscript presents the levels of six indicator polychlorinated biphenyl congeners 
(PCBs) (IUPAC nos. 28, 52, 101, 138, 153 and 180) in the serum of 1880 individuals from a 
representative sample of the Spanish working population recruited between March 2009 and July 
2010.   
 
Three out of the six PCBs studied (180, 153 and 138) were quantified in more than 99% of 
participants. PCB 180 was the highest contributor, followed by PCB 153 and 138, with relative 
abundances of 42.6%, 33.2% and 24.2%,respectively. In contrast, PCBs 28 and 52 were detected in 
only 1% of samples, whereas PCB 101 was detectable in 6% of samples. 
 
The geometric mean (GM) for the sumatory PCBs138/153/180 was 135.4 ng/g lipid (95% CI: 121.3-
151.2 ng/g lipid) and the 95th percentile was 482.2 ng/g lipid.  
 
Men had higher PCB blood concentrations than women (GMs 138.9 and 129.9 ng/g lipid respectively). 
As expected, serum PCB levels increased with age and frequency of fish consumption, particularly in 
those participants younger than 30 years of age. The highest levels we found for participants from the 
Basque Country, whereas the lowest concentrations were found for those from the Canary Islands.  
 
The Spanish population studied herein had similar levels to those found previously in Greece and 
southern Italy, lower levels than those in France and central Europe, and higher PCB levels than in the 
USA, Canada and New Zealand.  
This paper provides the first baseline information regarding PCB exposure in the Spanish adult 
population on a national scale. The results will allow us to establish reference levels, follow temporal 
trends and identify high-exposure groups, as well as monitor implementation of the Stockholm 
convention in Spain. 
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Reviewer #1:  
All the questions I had raised have been answered by the authors and the additional 
information required provided. 
 
The only issue I still find critical is the comparison with studies carried out in different years 
and, even more, the comparison with areas known to be among the most polluted in Europe, 
like Brescia.  
About this latter matter, I find the comparison with studies carried out on Brescia useless and 
misleading, and definitely think it should be eliminated with any loss of the paper significance. 
 
We have eliminated in the the text and in table 5 according to your suggestion. 
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Highlights 
 
 6 NDL-PCBs  serum levels reported in a representative sample of Spanish 
adults. 
 PCB congener 180 is the largest contributor to PCB load body burden. 
 Serum PCBs levels increased with the age and the frequency of fish consumption. 
 Basque country had the highest and Canary Islands the lowest PCB levels in the 
population. 
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This manuscript presents the levels of six indicator polychlorinated biphenyl congeners (PCBs) 
(IUPAC nos. 28, 52, 101, 138, 153 and 180) in the serum of 1880 individuals from a representative 
sample of the Spanish working population recruited between March 2009 and July 2010.   
 
Three out of the six PCBs studied (180, 153 and 138) were quantified in more than 99% of 
participants. PCB 180 was the highest contributor, followed by PCB 153 and 138, with relative 
abundances of 42.6%, 33.2% and 24.2%, respectively. In contrast, PCBs 28 and 52 were detected in 
only 1% of samples, whereas PCB 101 was detectable in 6% of samples. 
 
The geometric mean (GM) for 6PCBs138/153/180 was 135.4 ng/g lipid (95% CI: 121.3–151.2 ng/g lipid) 
and the 95th percentile was 482.2 ng/g lipid.  
 
Men had higher PCB blood concentrations than women (GMs 138.9 and 129.9 ng/g lipid 
respectively). As expected, serum PCB levels increased with age and frequency of fish consumption, 
particularly in those participants younger than 30 years of age. The highest levels we found for 
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participants from the Basque Country, whereas the lowest concentrations were found for those 
from the Canary Islands.  
 
The Spanish population studied herein had similar levels to those found previously in Greece and 
southern Italy, lower levels than those in France  and central Europe, and higher PCB levels than in 
the USA, Canada and New Zealand.  
This paper provides the first baseline information regarding PCB exposure in the Spanish adult 
population on a national scale. The results will allow us to establish reference levels, follow temporal 
trends and identify high-exposure groups, as well as monitor implementation of the Stockholm 
convention in Spain. 




The growing interest in protecting human health from the adverse effect of chemicals in the 
environment, diet and lifestyle is reflected by the development of international policies of different 
scope (European environment and health strategy, Minamata Convention, UNEP 2013a,b; REACH 
Regulations, EC 2006; Stockholm Convention, UNEP 2004; etc). Polychlorinated biphenyls (PCBs) are 
organic chemicals used in a variety of applications, such as in electrical capacitors, fluorescent lights, 
paints, sealants for construction, etc. These compounds are chemically and thermally stable, 
resistant to degradation and highly lipophilic. As a result, PCBs bioaccumulate in the environment, 
living organisms and food chains thereby resulting in significant human exposure and, in some cases, 
high body burdens (Wang et al., 2007; World Health Organization, 2002, 2000).  
PCBs are toxic to animals and humans and their toxicity is directly proportional to the degree of 
chlorination of the molecule. As such, PCBs are associated with a wide spectrum of adverse health 
effects and have recently been classified as carcinogenic to humans (Group 1) by the International 
Agency for Research on Cancer (IARC) (Lauby-Secretan et al., 2013). PCB exposure is also associated 
with endocrine disruption, reproductive disorders (Buck Louis et al., Codru et al., 2007; 2010; 
Diamanti-Kandarakis et al., 2009; Porta, 2006; Rylander et al., 2005; Schell et al., 2013) and 
neurological, immunological and dermatological effects (Fitzgerald et al., 2008; Grandjean & 
Landrigan, 2006). PCBs can cross the placenta to the foetus and have also been detected in breast 





































































characteristics justify their inclusion amongst the Stockholm convention “dirty dozen” chemicals 
(UNEP, 2004).  
PCBs have been targeted for elimination since the 1970s. In Spain, environmental restrictions 
initially came into force in 1999 and were strengthened in 2006 (R.D. 1378/1999 and R.D. 
228/2006). As a result, background PCB levels have decreased (Agudo et al., 2009; Harmag et al., 
2006; Schuhmacher et al., 2013), although they currently appear to have stabilised (Porta et al., 
2008).  
 
At a global level, the Stockholm Convention banned PCB production and use in May 2001 (UNEP, 
2004), and Regulation (EC) No. 850/2004 is the legal framework which gives effect to the provisions 
of this Convention in Europe. In Spain, the National Implementation Plan for the Stockholm 
Convention was approved in 2007 (http://www.magrama.gob.es/es/calidad-y-evaluacion-
ambiental/temas/productos-quimicos/pnestocolmofinal_31enero2007_tcm7-3187.pdf)  However, as 
an exception has been made to allow the use of PCB-containing equipment until 2025, important 
diffuse sources of PCBs continue to exist (Herrick et al., 2004), thus meaning that human exposure 
continues to occur. Amongst other actions, the treaty encourages the establishment of human 
biomonitoring (HBM) programs in the general population to check the effectiveness of treaty 
implementation. As a result, PCBs in humans have been measured in many countries over the last 20 
years, thus allowing the elimination trend to be monitored. In Spain, although the PCB level in the 
general population has been measured in different regions of the country (Agudo 2009), such as 
Catalonia (Porta et al., 2012, 2010), the Basque Country (Zubero et al., 2009), Madrid (Martínez et al., 
2009) and the Canary Islands (Henríquez-Hernandez et al., 2011), to date there has not been a 
nationwide study at a defined moment that is representative of the general population.  
 
In compliance with the Spanish national implementation plan for POPs, in 2007 the Spanish Ministry 
of Agriculture, Food and the Environment funded a national HBM program. The purpose of this 
program was to enhance current understanding of the distribution of priority environmental 
pollutants, such as metals, pesticides, flame retardants, perfluorinated compounds, PCBs etc., in 
Spain and to establish reference levels within the Spanish population. The ministerial action was 
planned in two stages. The first stage (2007-2010) included the BIOAMBIENT.ES project, a 
nationwide cross-sectional study, with stratified cluster sampling, designed to cover all geographical 
areas (including the Canary Islands and autonomous city of Ceuta) and occupational sectors, and 
aimed at obtaining a representative sample of the Spanish workforce (Esteban et al., 2013; Perez-





































































Herein we present the first baseline information regarding PCB exposure in the Spanish adult 
population on a national scale. The number of PCB congeners selected for analysis (IUPAC numbers 
28, 52, 101, 138, 153 and 180) will offer a good picture of general exposure to the most 
representative non-dioxin-like PCBs (NDL-PCB)  (Wingfors et al., 2006).  
The results obtained will provide the first nationwide fingerprint of NDL-PCB burden in Spanish 
adults and will allow us to identify high-exposure regions or population groups as well as enabling 
comparisons with other countries. They will also allow environmental policymakers to establish the 
relative European or world-wide position of Spain regarding PCB exposure, to follow temporal 
trends and to check the degree of implementation of actions taken in compliance with the Spanish 
national implementation plan for POPs.  
2. Materials and Methods 
2.1. Study Population 
From March 2009 to July 2010, a total of 1936 subjects residing in all 17 Spanish Autonomous 
Communities and the autonomous city of Ceuta were recruited. Participants were workers aged 18 
years or older who had been resident in Spain for five years or more and attended the health facilities 
of the Societies for Prevention of IBERMUTUAMUR, MUTUALIA, MCPREVENCIÓN, MUGATRA, 
UNIMAT PREVENCIÓN, and PREVIMAC. The design and field work have already been described in 
detail elsewhere (Esteban et al., 2013; Perez-Gomez et al., 2013). Briefly, participants agreed to 
donate biological samples and to complete a short self-administered epidemiological questionnaire 
on environmental and lifestyle-related exposures. Of the 1936 subjects recruited, the amount of 
blood was insufficient for the analytical determination in 12 cases and no information was available 
on the stratification variables in 44 cases. As a result, PCB congeners were determined using the 
serum from 1880 individuals. 
2.2 Ethical approval  
This study was approved by both the Ethical Committee and the legal department of 
IBERMUTUAMUR. Participants were asked to provide written informed consent. Their collaboration 
was voluntary and altruistic; only a small token pen drive was given to the participants. The study 
was performed in accordance with legal/ethical principles and regulations concerning research 
involving individual information and biological samples, including Organic Law 15/1999 on Personal 
Data protection and its Regulations, Law 41/2002, on the Autonomy of Patients and rights and 
obligations relating to health information and documentation, as well as General Health Law 





































































of Helsinki and those contained in the UNESCO Universal Declaration on the Human Genome and 
Human Rights were observed. 
 
2.3 Biological Sampling and Storage 
Fasting blood specimens were collected in S-Monovette® neutral tubes (Sarstedt Nümbrecht, 
Germany) by trained healthcare staff. Blood samples were centrifuged within 5 hours of collection 
and transported at 4ºC within 96 hours post-sampling (Esteban et al., 2013). In the laboratory, 
samples were left to rest for approximately 60 min at room temperature, then the sample was 
centrifuged again and the serum separated. As the BIOAMBIENT.ES project included, among others, 
the study of several POPs in human serum, we tried to reduce volumes as much as possible. Thus, we 
prepared small serum aliquots (0.5 mL) in glass vials and stored them at -20ºC until analysis.  
 
2.4 Extraction and Analysis 
Individual standard solutions (10 ng/PL in isooctane) of the six PCBs (IUPAC numbers 28, 52, 101, 
138, 153 and 180) were purchased from Ehrenstorfer (Augsburg, Germany). Individual and working 
standard solutions as well as 13C12-PCB 118 internal standard solution (Wellington Laboratories Inc., 
Guelph, Canada) were prepared in hexane and stored in the dark at 4ºC (range 2-10ºC). 
Because of the matrix effect, rabbit serum was used as “blank” in the spiked calibration curves. 
Rabbit serum was selected because it presents the lowest PCB levels when compared to horse, calf, 
pig and human serum samples. Rabbit serum blanks and blank reagent samples (demineralized 
water) were analyzed to identify any contamination during the analytical procedure.  
Prior to extraction, all samples were spiked with a known quantity of a solution containing 13C12-PCB 
118 and deproteinized with formic acid (Merck, Darmstadt, Germany). These aliquots (0.5 mL) were 
extracted by solid-phase extraction (SPE) using an OASIS cartridge (Waters, Milford, USA) and the fat 
subsequently eliminated on-line by dropping the eluate directly onto a second glass cartridge (J.T. 
Baker, The Netherlands) containing layers of activated neutral silica gel and sulphuric acid (Merck, 
Darmstadt, Germany) modified silica gel (Gomara et al., 2002). The eluate obtained was evaporated 
to dryness under a slow stream of nitrogen in a TurboVap LV evaporator (Zymark, Hopkinton, MA; 
USA) then dissolved in 50 PL of hexane. All solvents used for extraction and clean-up were Pestipur 
quality (Lab Scan, Dublin, Ireland). 
Finally, the extracts were transferred to a vial with a glass insert (Agilent Technologies Inc, Palo Alto, 





































































temperature of 260ºC, in an Agilent Technologies HP7890A gas chromatograph system with a mass 
spectrometer detector (HP 5975A). The source was set to operate in negative-ion chemical ionization 
mode (GC-MS/NCI), with methane as reagent gas and helium as carrier gas, both of high-purity grade 
(Air Liquide, Madrid, Spain). Samples were analysed using a DB-5-ms (or similar) capillary column 
(Agilent; 5% diphenyl, 95% dimethylpolysiloxane column, 15 m x 0.25 mm id. x 0.25 Pm stationary 
phase). Temperatures were programmed as follows: MS interface temperature 270ºC; oven 
temperature 100 ºC for 4.2 min, 40 ºC/min to 200 ºC, then 7 ºC/min to 219 ºC, held for 0.2 min, then 
56ºC/min to 275 ºC, held for 3 min to a final temperature of 300ºC, held for 3 min. The total runtime 
was about 17.24 min. 
The PCB concentrations obtained were individually lipid-adjusted and total cholesterol and 
triglycerides were also measured (Bernert et al., 2007). PCBs with concentrations below the LOQ 
were reported as LOQ/2. Limits of quantification (LOQ) expressed in ng/mL and in ng/g lipid for 
serum samples can be found in Table 1.  
External quality assurance during our analysis was guaranteed by means of participation in 
intercomparison exercises: in Round 3 of 2010 and Round 2 and 3 of 2011 of the AMAP Ring Test 
(National Institute of Public Health, Quebec, Canada), with a z-score of between 1.11 and -0.70, and 
in G-EQUAS 46 and 47 from 2010 and 2011, respectively (German External Quality Assessment 
Scheme, Erlangen, Germany). All values were within the range of tolerance.  
 
2.5 Statistical analysis  
Because of the complex survey design (multi-stage stratified cluster sampling) and the different 
selection probabilities of study participants (small geographical areas, non-service economic sectors, 
and women were over-sampled) (Perez-Gómez et al., 2013), all analyses were weighted to the 
distribution of the employed Spanish population in 2009 (National Institute of Statistics, 2009) and 
taking the effect of stratification and clustering on point and interval estimates into account. 
 
Basic descriptive statistics were calculated for PCBs 138, 153 and 180 individually and for their sum 
∑PCBs138,153,180 (from this point forward we will use ∑PCBs to refer to the sum of these 3 PCB 
congeners). Statistics include the arithmetic mean (AM), geometric mean (GM) and their confidence 
intervals (95%), as well as percentiles 10, 25, 50, 75, 90 and 95 for the entire study population. In a 
second step, the same statistics were calculated for the following subgroups: men and women, 
economic activity sector (service activities and farming, industry and construction activities), 





































































Northeast I (Navarre, La Rioja, Aragon), Northeast II (Catalonia), Central I (Castile and Leon), Central 
II (Madrid), Central III (Castile-La Mancha, Extremadura), East (Valencian Community, Balearic 
Islands), South I (Andalusia, Ceuta), South II (Murcia) and Canary Islands), sampling quarter 
(January–March, April–June, July–September, and October–December), age groups (≤29, 30-39, 40-
49, ≥50 years), and fish and shellfish consumption (<once per week, once per week, 2/4 times per 
week, ≥5 times per week).  
 
Multivariate linear regression models were fitted using log-transformed ∑PCBs levels as the 
dependent variable, and including age, sex (reference category was women), economic sector 
(reference category was services) fish and shellfish consumption (reference category was once per 
week), geographical area and sampling quarter. The exponentiated beta coefficients of the models 
represent the proportional change in the geometric mean of ∑PCB concentration for the different 
levels of the variables studied, compared to a reference category as independent variables. 
 
Statistical analyses were carried out using survey modules for complex design studies (STATAv11.0), 
and maps were prepared using R and ArcView using the ratio between the geometric mean in each 




PCBs 138, 153 and 180, the main PCB markers of environmental pollution and those with the longest 
half-lives (penta- to heptachlorinated biphenyls), were quantified in at least >90% of the samples 
analyzed. As a result, a new variable was computed as the sum of PCBs 138, 153 and 180 (∑PCB). 
The median value of ∑PCB is 143.6 ng/g lipid, the geometric mean (GM) is 135.4 ng/g lipid (121.3–
151.2 ng/g lipid) and the 95th percentile is 482.2. Samples below LOQ for PCBs 138, 153 and 180 
were 0.88%, 0.57% and 0% respectively. 
 
Congeners 28 and 52, which undergo fast enzymatic degradation in animals and humans, were 
detected in 1% of samples. PCB 28 was detected in only one person, with a value of around 7 ng/mL 
serum.  PCB 101 was detected in just 6% of participants. As a result, these three PCB congeners 
were not included in the statistical analyses.  
 
Table 2a shows the descriptive statistics for ΣPCBs in serum for all participants, whereas Tables 2b 





































































PCB levels than women, with geometric means of 139.9 (95% CI: 124.3–157.3) and 129.9 ng/g lipid 
(95% CI: 129.9–147.1) respectively.  
The highest contribution to the PCB load was found for PCB 180, with a GM of 55.97 ng/g lipid (95% 
CI: 49.5–63.2), followed by PCB 153, with a GM of 43.61 ng/g lipid (95% CI: 38.85–48.95), and PCB 
138, with a GM of 31.89 ng/g lipid (95% CI: 28.81–35.30; Table 3).  
As is generally the case for pollutants that bioaccumulate over time, an increase in the 
concentration of PCBs with age was found. Thus, PCB levels increase by approximately 56% per 10 
years of age, and are slightly higher in men than in women, except for the older groups. On average, 
PCBs in men are 9% higher than those in women. However, there is a statistically significant 
interaction between sex and age, and these differences are mainly due to the contrast between PCB 
levels in the over-50 years age group (Figure 1).  
No statistically significant differences were observed by economic sector, with the values only being 
significantly higher in workers who do not belong to the service sector in the case of the oldest 
group. Irrespective of the occupational sector to which they belong, men always have higher PCB 
levels than women. 
As regards geographic differences, the concentrations of ΣPCB congeners in samples from Northeast 
and Northern Spain were higher than those reported in the South of Spain, with the GMs for 
Asturias-Cantabria and the Basque Country being 45% and 88% higher than the Spanish average, 
respectively. The lowest concentrations were found for the Canary Islands, with a GM of 78.9 ng/g 
lipid. Figure 2 presents the ratio of GMs for the serum ΣPCB concentration for different geographic 
regions.  
As far as the distribution of PCB levels per sampling quarter is concerned, these levels were higher in 
the samples collected during the second quarter of the year (April–June), whereas the lowest GM 
was found for the last quarter (September–December). The biggest differences were found for PCB 
180, with the value for the second quarter being almost twice that for the fourth. 
Serum PCB levels increased with the frequency of weekly fish consumption. Thus, 44% of 
participants ate fish between two and four times a week, and 13% more often than that, with 
women consuming 10% more fish than men. People who reported eating fish less than once or once 
per week (12% and 31% of the participants, respectively) had lower PCB levels than those eating fish 
two or more times per week (57%). This increase is more evident in the youngest group. For a 





































































although the differences do not reach statistical significance. We did not find significant differences 
in serum PCBs among those subjects who reported eating fish more than twice per week and those 
eating fish four or more times per week (Figure 3). 
The results of the multivariate analysis are presented in Table 4 for the whole population studied 
and for men and women separately. These results are consistent with the patterns of the basic 
descriptive statistics shown in Tables 2a to 2c, although significant differences become evident for 
some determinants. Thus, women had 9% lower serum PCB levels than men, and the oldest group 
(>50) had three times more PCBs in serum than the youngest group (<29 years) after adjusting for 
other factors. Body mass index (BMI) was not included in the models since it does not seem to 
significantly affect PCB levels. 
4. Discussion 
The work presented here offers the first data on body burden for the most relevant NDL-PCBs in 
Spanish adults. 
As reported for many other industrialized countries and in previous studies in some Spanish regions, 
PCBs 138, 153 and 180 were detected in more than 90% of our population (Agudo et al., 2009; Bates 
et al., 2004; CDC, 2009, 2005; Cerna et al., 2008; De Felip et al., 2008; Glynn et al., 2000; Heudorf et 
al., 2002; Longnecker et al., 2000; Park et al., 2007; Patterson et al., 2009; Porta et al., 2012; Turyk et 
al., 2006; Zubero et al., 2009).  
As is the case in many other countries, PCBs 180 and 153 can be assumed to be major contributors 
to the PCB load in the Spanish population, although the predominance of each congener varies 
between studies. The major contributor in BIOAMBIENT.ES was found to be PCB 180, whereas 
Zubero and co-workers found that PCB 153 was most prevalent in volunteers resident in the Basque 
Country, followed by PCB 180 and 138 (Zubero et al. 2009). A similar predominance was also found 
in a multiregional study conducted in five Spanish regions in 1992-1996 (Agudo et al., 2009), as well 
as in the Canary Islands in 1998 (Henriquez et al. 2011) and in Catalonia in 2002 (Porta et al 2010).   
Also in accordance with other authors (Cerna et al., 2012), PCB congeners 28, 52, and 101 were, in 
general, below the limit of quantification (LOQ) in the general population except in the case of 
specific exposure to indoor air contamination (Kohler et al., 2005; Wingfors et al., 2006). Gabrio et 
al. (2000) and Schwenk et al. (2002) have reported elevated indoor PCB air concentrations 





































































reported statistically significant associations between indoor-air and serum concentrations for PCB 
28 (Fitzgerald et al., 2011).  
PCB concentrations in humans are known to be significantly associated with different factors, the 
most significant of which is age due to their bioaccumulative character. A positive correlation 
between age and serum PCB levels was also observed in our study. Thus, the GM for ¦PCB138,153,180 
concentrations was almost three times higher in the oldest group (250.5 ng/g lipid) than in the 
youngest (72.0 ng/g lipid) as a result of past cumulative exposures and the long half-life of these 
pollutants (De Felip et al 2008; Porta et al., 2010, 2008; Wolff et al., 2007). In addition, 
environmental exposure has decreased with time since PCB production was banned. Older 
participants were born at a time when they were exposed to higher background levels and therefore 
they are likely to have accumulated a higher body burden throughout their lives (Collins et al., 
2007). It has also been suggested that this correlation with age may be related to differences in PCB 
metabolism, which is lower in elderly people (Bates et al., 2004; Fangstrom et al., 2005; Park et al., 
2007; Schulz et al. 2009; Wolff et al., 2007). 
As regards the presence of PCBs in men and women, our results are consistent with the available 
literature (Agudo et al., 2009; Apostoli et al., 2005; Burns et al., 2009; Cerna et al., 2008; Henríquez-
Hernández et al., 2011; Park et al., 2007; Petrik et al., 2006; Zubero et al., 2009) in which the sum of 
PCB congeners tended to be higher in men than in women. Some exceptions to this have been 
reported, such as the study by Porta and co-workers in Catalonia, in which women presented a 
statistically significantly higher median concentration of the most prevalent PCBs than men after 
adjusting for age and BMI (Porta et al., 2012).  
There is no clear explanation for these gender-related differences in PCB levels.. The major 
determinants of human polychlorinated biphenyl (PCB) body burden include a mixture of external 
and internal factors, including source, route and timing of exposure along with individual 
determinants such as uptake, metabolism and clearance (De Caprio et al., 2005, Gladen et al., 2003; 
James et al., 2002). Some authors have justified the higher concentrations of PCBs in men than in 
women on the basis of differences in diet, occupational exposures or metabolism (Bates et al., 2004; 
Glynn et al., 2003; Patterson et al., 2009; Porta et al., 2010; Schaeffer et al., 2006; Wolff et al., 2007). 
In our study we observed much higher age-related increases for PCBs in men than in women, with 
women older than 50 presenting three times more PCBs than the youngest participating females and 
men in the oldest group presenting four times more than the youngest group after adjusting for 





































































differences. Metabolic differences between genders could be one of them. Breastfeeding could also 
be an additional route by which these compounds are eliminated therefore women who have had 
children and have breastfed may have lower concentrations of these compounds. 
Diet may be an important source of PCBs in humans. In our population, fish consumption, which 
forms an essential part of the Spanish diet, has a clear influence on the increase of PCB levels in the 
youngest group of volunteers (<29 years), whereas this influence was not so evident in older groups 
(Figure 3). High levels due to contaminated food consumption have also been reported in other 
European studies (Abad et al., 2002; Zuccato et al., 2008). Agudo et al. (2009) explored the 
association between dietary factors and serum PCB concentrations. These authors selected five food 
groups, all of them of animal origin (meat, fish, seafood, dairy products (without milk) and fat and 
oils) and found that the serum PCB concentration was strongly associated with fish intake.  Other 
studies have also shown that the major source of exposure to these compounds is the diet, 
particularly the consumption of fatty fish (Bocio et al., 2007; Bordajandi et al., 2006, 2003). 
However, fish consumption cannot justify the different PCB levels found for participants from 
different Spanish regions per se. 
The geographical differences found in our results could be associated with the use of PCB-containing 
equipment in the different regions. The results of the multivariate analysis showed that the 
geographical differences in serum PCB concentrations persisted after adjusting for age, sex, 
economic sector, sampling quarter and fish consumption.  In our study serum PCB concentrations 
were markedly higher in participants living and working in northern regions. These results are 
consistent with data provided by the Spanish Ministry of Agriculture, Food and the Environment, 
which show that the highest number of inventoried PCB-containing devices are found in the Basque 
Country (17925.46 tonnes as of 31 December 2010) versus the 1267.58 tonnes for the Canary 
Islands (MAGRAMA, 2013). The wide range of levels found across regions highlights the importance 
of studying local sources of exposure.  
Our results confirm the findings of previous Spanish studies. Thus, over four years (1992-1996) 
Agudo and co-workers recruited volunteers aged 35-64 years in five Spanish regions, three from the 
North (Asturias, Guipuzcoa and Navarra) and two from the South (Granada and Murcia) and found 
that the values for Guipuzcoa (in the Basque Country) were around 35% higher than those found for 
Granada (South of Spain) (Agudo et al., 2009). Henriquez and co-workers also found the lowest 
levels of PCB exposure in inhabitants of the Canary Islands (Henriquez et al., 2011). In addition to 





































































of fish in the country according to a recent report from the Spanish Ministry of Agriculture, Food and 
the Environment (MAGRAMA, 2011). 
We found seasonal differences in PCB levels, with the highest levels being found in April-June and 
the lowest in October-December. Given that the frequency of fish consumption, age and other 
confounders have all been considered in the multivariate analysis model, we have no clear 
explanation for this phenomenon. It could be that some variations in food habits, associated with 
seasonality, or interferences with the geographic zone could explain the observed data. Although 
the geographical distribution was included in the multivariate data-analysis model, the fact is that 
most volunteers from the Basque country (the highest concentrations in Spain) were recruited in the 
first two quarters whereas volunteers from the Canary Islands (with the lowest concentrations in 
Spain) were predominantly recruited in the second half of the year. In light of this, more detailed 
studies should be performed to confirm the season variability of PCB levels.  
With respect to BMI, although the lack of an association (Baris et al., 2000; Schaeffer et al., 2006) or 
a positive association (Fernandez et al., 2008) with BMI have been reported, most studies have 
found a negative association, i.e. PCB levels in circulating blood decrease with increasing BMI 
(Agudo et al., 2009; Bachelet et al., 2011; Cerna et al., 2008; Glynn et al., 2003; Porta et al., 2012; 
Wolff et al., 2007). A similar pattern was observed with our data, with PCB concentrations 
decreasing with increasing BMI (Table 2a). Accumulation in body fat deposits in those subjects with 
a higher BMI is one of the likely causes for this negative association (Dhooge et al., 2010). 
One of our critical concerns is to determine how much human serum PCB levels have decreased since 
the ban. The overall trend is that serum PCB levels have been decreasing since the 1980s. In the study 
carried out by Agudo (Agudo et al., 2009), although samples were collected over a relatively short 
period, the PCB concentration was, on average, 12% higher in samples from 1993 than in those from 
1995, and between two and three times higher than the PCBs levels found in our study. A similar 
situation was observed by Porta and co-workers, in Barcelona, in 2002 and 2006, where ∑PCB138,153,180 
in serum decreased by around 30% and by almost 50% in the youngest age groups (Porta et al.,2012 
and 2010). The ∑PCB values found by BIOAMBIENT.ES in Catalonia (GM 170.3 ng/g lipid) are much 
lower than those found in 2002 (GM 229.8 ng/g lipid) and very similar to the results for 2006 (166.4 
ng/g lipid; Porta et al., 2012, 2010). Our ∑PCB138,153,180 values for samples from the Basque Country 
(GM of 277.3 ng/g lipid) are in the same range as those obtained in a study conducted in 2006 in the 
same region (GM 232.94 ng/g lipid; Zubero et al., 2009). This suggests that the PCB ban in Spain has 





































































Effectiveness is obviously greater as the observance period increases. Thus, a 33% reduction in PCB 
153 levels was reported over a 10-year period (1991-2001) in Sweden (Hagmar 2006). The PCB levels 
in Spanish samples have dropped considerably since 1988, and between 2002 and 2004 the levels 
were two times lower (Gomara et al., 2011; Bordajandi et al., 2008). 
A significant decrease in PCB levels in human milk between 1984 and 2003 was also reported by 
Wilhelm et al. (2007) in Germany and by Schuhmacher et al., (2013) between 1998 and 2012, in 
Catalonia, with the decrease reaching almost 70%. This downward trend is more prominent for PCB 
153 than for PCB 180 (about seven times versus five times lower, respectively) when comparing 
breast milk samples from 1984 to 2003 (Wilhelm et al 2007) and with serum samples from 1991 and 
2001 (Hagmar 2006) and from 2000 to 2005 in Romania (Dirtu et al, 2006). This finding could explain 
the variation in predominance found in our results when compared with previous Spanish studies in 
which PCB 153 was found in the highest concentrations (Herriquez-Hernández et al., 2011; Porta et 
al., 2012, 2010; Zubero et al., 2009).  
At a European level, the PCB concentrations found in our study are lower than those reported from 
Germany (GerESIII; Becker et al., 2002), although the surveys were performed almost 10 years apart 
(GerESIII in 1998 and BIOAMBIENT.ES in 2009-2010). Taking this fact into account, our values are 
almost half those for PCBs 138 and 153, whereas the values for PCB 180 (the most persistent 
congener) are similar (Table 5). 
In contrast, it is clear that the Spanish population is less exposed to PCBs than the French (Fréry et al., 
2012). Thus, the levels for PCBs 138 and 153 in a survey from 2006-2007 were similar to those found 
in the German population from 1998 and therefore up to twofold higher than ours in 2009 and the 
GM for ∑PCB138,153,180. The concentration obtained for PCB 180 in the French study was higher than 
both the German values and ours (Table 5). 
The values obtained in a study conducted in five urban areas in the Czech Republic in 2006 (Cerna et 
al., 2008) were between six and ten times higher than those found by Bioambient.es (Table 5), 
whereas the levels found in Slovakia in 2001 (Petrik et al., 2006) were between four and five times 
higher than those found in our population (Table 5). 
 A recent study in volunteers aged between 18 and 64 years from urban and rural areas around 
Naples (Italy) found similar levels for the three main PCB congeners to those found in our study 





































































et al., 2004) (Table 5). In general, similar results were found in southern European countries and 
lower than those for central Europe (Table 5).   
Over the past 20 years, PCB 153 has been found to be the major contributor in the serum of 
populations from most countries (Frery et al., 2013; CDC 2009; Becker et al, 2002). As shown in 
several studies (Hagmar et al. 2006; Dirtu et al. 2006; Wilhelm et al. 2007;  Esposito et al. 2013), the 
levels of this PCB have decreased to a greater extent than those of PCB180, which contains a higher 
number of chlorinated positions. We have observed a similar effect in our samples, in which PCB 180 
is the main contributor to the PCB body burden.  
Spanish levels are still higher than those found in the general population of the USA, Canada and New 
Zealand even though sampling in these populations was conducted some years ago (Bates et al., 
2004; CDC 2009, 2005; Haines et al., 2012; Health Canada, 2010) (Table 5). In the USA study, PCBs 
levels decreased by approximately 20% between 2002 and 2004.   
5. Conclusion 
This paper presents the first data regarding PCB levels in a representative sample of the Spanish 
working population. As the participants in our study were not occupationally exposed, in practical 
terms the sample can be considered to be representative of the general population and therefore the 
levels can be interpreted as a reference for Spanish adults at a national level. The few comparisons 
we have been able to make with available local studies confirm the reduction in PCB levels in some 
regions of Spain. 
In our volunteers we have found a change in the abundance of PCB congeners with respect to 
previous Spanish studies, with PCB 180 being the largest contributor to PCB burden in volunteers 
from all Spanish regions and all age groups. As such, we propose to use this PCB as a marker to follow 
trends in future variations in the body burden of PCBs in the general population and to check the 
implementation of environmental POP reduction policies. 
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  LOQ (ng/mL) LOQ (ng/g lipid) 
PCB28 1 58.94  
PCB52 1 58.94  
PCB101 0.2 11.79  
PCB138 0.01 0.59  
PCB153 0.01 0.59  
PCB180 0.005 0.29  
 
Table 1: Limits of quantification (LOQ) for each PCB congener expressed in ng/mL and ng/g 
lipid in serum samples. 
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TOTAL 
  Variables N GM* 95% CI AM* 95% CI   P10 P25 P50 P75 P90 P95 
Total                                   
    1880 135.4 121.3 - 151.2 187.5 162.4 - 212.7   48.9 81.9 143.6 230.1 359.4 482.2 
Sex   
  Men 963 139.9 124.3 - 157.3 191.7 169.6 - 213.9   49.8 85.0 147.2 237.5 374.6 556.0 
  Women 917 129.9 114.8 - 147.1 182.1 150.5 - 213.7   46.6 79.3 137.5 218.2 342.4 437.9 
Age   
  ≤29 years 372 72.0 63.3 - 81.8 97.8 84.2 - 111.4   25.7 47.9 73.1 119.4 189.3 244.8 
  30-39 years 762 120.7 107.0 - 136.2 153.6 132.0 - 175.3   51.1 81.3 128.0 188.2 275.4 365.9 
  40-49 years 466 188.1 166.3 - 212.8 243.2 200.9 - 285.6   74.0 125.9 189.9 280.3 394.4 599.1 
  ≥50 years 268 250.5 226.3 - 277.4 309.9 275.2 - 344.5   91.6 150.3 254.9 364.5 561.5 705.2 
Economic sector   
  Other sectors 657 134.5 115.5 - 156.8 191.9 164.8 - 219.0   46.3 81.2 151.4 232.6 382.7 524.7 
  Services 1223 135.8 119.6 - 154.1 185.8 156.3 - 215.3   50.9 82.3 140.6 227.9 352.9 465.5 
Geographical area   
  Galicia 146 128.4 107.2 - 153.8 168.1 149.7 - 186.4   52.3 80.8 147.8 204.0 306.5 377.4 
  Asturias, Cantabria 99 208.8 150.1 - 290.5 266.8 190.9 - 342.7   73.1 115.6 218.4 351.3 542.0 631.6 
  Basque Country 148 277.3 244.5 - 314.5 340.6 310.4 - 370.7   117.9 180.9 267.1 430.4 637.0 830.8 
  Navarre, La Rioja, Aragon 145 118.1 96.1 - 145.1 168.5 135.2 - 201.9   41.8 74.0 136.1 219.1 341.7 432.2 
  Catalonia 248 170.3 112.4 - 258.0 237.7 106.7 - 368.7   65.3 104.4 168.9 261.8 470.5 642.8 
  Castile and Leon 154 102.5 80.6 - 130.2 138.9 114.4 - 163.3   33.2 58.8 113.1 183.1 278.5 383.5 
  Madrid 197 125.9 89.5 - 177.1 166.5 121.9 - 211.2   42.9 76.7 145.7 218.2 326.7 359.4 
  Castile-La Mancha, Extremadura 150 136.5 116.9 - 159.5 183.3 144.0 - 222.7   53.7 78.8 138.1 229.1 336.9 524.7 
  Valencian Community, Balearic Islands 206 146.6 104.0 - 206.6 192.2 145.6 - 238.7   52.8 100.4 163.2 262.0 366.5 475.7 
  Andalusia, Ceuta 240 102.6 77.3 - 136.2 139.6 94.5 - 184.7   39.8 64.8 111.8 175.6 260.0 338.7 
  Murcia 97 126.0 98.4 - 161.5 176.8 114.3 - 239.4   37.7 78.1 133.1 221.4 371.2 460.2 
  Canary Islands 50 78.9 73.9 - 84.3 88.3 83.6 - 93.0   38.8 59.3 86.1 112.2 129.3 171.7 
Sampling Quarter   
  January - March 349 145.9 131.1 - 162.3 186.1 167.3 - 205.0   59.0 101.7 156.7 240.4 339.1 399.7 
  April - June 562 171.3 141.5 - 207.4 229.8 166.4 - 293.2   67.8 104.0 176.6 275.4 425.6 596.8 
  July - August 375 134.0 107.7 - 166.7 186.8 142.1 - 231.4   51.4 81.2 138.4 236.6 374.0 565.3 
  September - December 559 101.8 85.9 - 120.7 144.3 119.5 - 169.1   36.0 62.0 119.2 190.1 305.5 358.1 
Frequency fish consumption   
  <Once per week 212 91.2 76.7 - 108.4 126.5 109.4 - 143.6   29.1 57.1 109.4 179.5 275.8 364.6 
  Once per week 574 117.5 102.3 - 134.8 158.0 137.7 - 178.2   44.9 73.3 122.9 201.2 321.5 412.6 
  2/4 times per week 835 158.5 144.0 - 174.6 212.7 187.3 - 238.0   57.5 98.8 163.5 267.6 387.9 524.7 
  ≥5 times per week 221 157.5 125.3 - 198.0 225.9 157.3 - 294.6   51.4 91.5 159.0 261.0 476.7 596.8 
BMI   
  Normal (<25) 1489 137.0 121.0 - 155.0 190.6 161.3 - 219.9   51.1 83.1 144.0 232.4 365.2 493.4 
  Overweight (25-30) 289 129.7 116.0 - 145.0 176.7 157.7 - 195.7   44.1 79.3 143.8 227.4 344.9 407.6 
  Obesity (>30) 60 131.3 103.0 - 167.3 172.1 127.6 - 216.6   45.8 80.8 152.5 190.1 326.7 460.2 
 
Table 2a: PCBs descriptive analysis statistic for all participants by sex, age, economic activity sector, Autonomous 
Community, sampling quarter, frequency of fish consumption and Body Mass Index. Geometric mean (GM*), 
arithmetic mean (AM*) and their confidence intervals (95%) of the ΣPCB 138, 153 and 180 expressed in ng/g lipid, 
as well as percentiles 10, 25, 50, 75, 90 and 95.  
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  Variables N GM* 95% CI AM* 95% CI P10 P25 P50 P75 P90 P95 
Men                                 
    963 139.9 124.3 - 157.3 191.7 169.6 - 213.9 49.8 85.0 147.2 237.5 374.6 556.0 
Age                                 
  ≤29 years 178 66.8 56.6 - 78.9 88.5 76.3 - 100.7 28.3 44.9 71.1 112.1 159.1 227.4 
  30-39 years 377 123.0 106.9 - 141.7 157.0 130.7 - 183.2 51.4 80.3 127.3 192.1 281.3 380.5 
  40-49 years 256 185.7 166.2 - 207.5 231.3 206.1 - 256.4 72.6 121.8 185.2 271.3 395.5 617.6 
  ≥50 years 142 283.0 251.7 - 318.1 334.6 294.1 - 375.1 98.9 166.2 284.8 374.9 596.8 711.7 
Economic sector                               
  Other sectors 411 135.9 116.8 - 158.0 193.9 167.3 - 220.4 46.5 81.2 154.4 235.4 380.5 525.2 
  Services 552 142.7 124.7 - 163.3 190.3 164.5 - 216.0 51.4 86.0 144.4 242.7 370.9 569.1 
Geographical area                               
  Galicia 74 135.3 104.8 - 174.7 167.2 131.1 - 203.3 55.6 91.1 152.9 204.0 334.8 377.4 
  Asturias, Cantabria 49 226.0 164.6 - 310.3 285.8 214.7 - 357.0 103.3 159.7 233.1 351.3 525.2 663.1 
  Basque Country 74 268.1 252.1 - 285.2 337.8 330.0 - 345.6 105.9 165.5 267.1 509.6 637.0 743.8 
  Navarre, La Rioja, Aragon 78 115.1 80.5 - 164.6 180.5 128.8 - 232.2 33.8 73.8 122.4 243.0 380.5 502.6 
  Catalonia 123 171.6 103.8 - 283.7 233.5 118.1 - 348.9 51.9 104.4 183.5 290.7 569.1 642.8 
  Castile and Leon 78 107.3 84.3 - 136.7 138.8 120.2 - 157.4 44.1 58.8 117.5 189.6 278.5 335.5 
  Madrid 92 133.6 101.9 - 175.2 173.9 143.5 - 204.2 47.9 78.4 148.7 235.4 339.1 364.5 
  Castile-La Mancha, Extremadura 80 161.4 143.3 - 181.8 218.9 181.0 - 256.8 59.0 90.1 169.0 292.8 407.6 565.3 
  Valencian Community, Balearic Islands 110 147.8 97.2 - 224.8 198.8 142.6 - 255.0 54.6 104.0 163.2 251.4 375.1 477.4 
  Andalusia, Ceuta 122 106.4 84.2 - 134.3 136.6 104.5 - 168.6 47.9 65.5 107.6 176.6 269.1 338.7 
  Murcia 59 125.8 79.4 - 199.4 184.9 73.6 - 296.2 37.7 82.8 129.3 221.4 394.4 614.8 
  Canary Islands 24 79.1 77.7 - 80.5 87.1 85.8 - 88.4 38.8 60.7 86.9 114.4 129.3 135.9 
Sampling quarter                               
  January - March 159 151.8 128.1 - 179.9 201.7 169.0 - 234.5 51.7 98.9 159.6 242.7 349.4 476.7 
  April - June 310 180.0 149.8 - 216.4 234.3 185.7 - 282.9 71.1 104.4 189.6 292.8 461.2 625.6 
  July - August 180 131.1 101.1 - 170.0 191.1 142.7 - 239.6 47.9 75.3 135.9 225.2 421.8 595.4 
  September - December 299 109.5 91.7 - 130.8 147.6 126.2 - 169.1 43.7 68.5 127.1 192.2 310.6 347.2 
Fish and shellfish consumption                               
  <Once per week 123 97.9 80.4 - 119.2 132.1 112.8 - 151.4 39.0 62.1 123.1 191.6 280.3 364.5 
  Once per week 322 119.2 100.7 - 141.1 162.1 136.4 - 187.8 44.9 73.6 128.0 206.6 335.4 432.7 
  2/4 times per week 390 170.2 152.8 - 189.6 222.7 201.0 - 244.5 59.4 102.8 171.3 298.5 425.6 612.0 
  ≥5 times per week 106 166.9 166.9 - 216.4 235.8 164.9 - 306.6 51.4 91.1 166.6 284.8 556.0 596.8 
BMI                                 
  Normal (<25) 680 141.5 124.0 - 161.4 195.0 168.5 - 221.5 51.9 85.7 144.8 241.0 391.8 564.3 
  Overweight (25-30) 218 137.6 120.5 - 157.1 185.5 164.9 - 206.1 46.1 84.6 159.1 236.4 358.1 407.6 
  Obesity (>30) 43 129.7 102.6 - 164.0 171.2 121.7 - 220.6 55.6 76.9 158.6 190.1 326.7 460.2 
 
Table 2b: PCBs levels for men in according to age groups, economic activity sector, geographical area, sampling trimester, fish and shellfish consumption 
and Body Mass Index. Geometric mean (GM*), arithmetic mean (AM*) and their confidence intervals (95%), of the ΣPCB 138, 153 and 180 expressed in 
ng/g lipid, as well as percentiles 10, 25, 50, 75, 90 and 95.  
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  Variables N GM* 95% CI AM* 95% CI P10 P25 P50 P75 P90 P95 
Women                                 
    917 129.9 114.8 - 147.1 182.1 150.5 - 213.7 46.6 79.3 137.5 218.2 342.4 437.9 
Age                                 
  ≤29 years 194 77.8 64.6 - 93.5 107.5 84.5 - 130.4 25.3 51.1 76.3 124.9 217.6 280.9 
  30-39 years 385 118.1 105.0 - 132.7 149.7 130.3 - 169.0 47.3 84.1 128.9 186.3 265.6 346.1 
  40-49 years 210 191.9 157.7 - 233.4 261.4 173.2 - 349.6 75.3 128.9 196.5 294.4 381.1 566.9 
  ≥50 years 126 208.6 184.5 - 235.7 272.5 228.0 - 317.1 87.9 113.6 210.8 306.5 444.3 612.4 
Economic sector                               
  Other sectors 246 129.0 103.1 - 161.3 183.5 142.4 - 224.6 36.2 75.5 139.3 220.5 399.7 482.2 
  Services 671 130.1 112.8 - 149.9 181.9 146.6 - 217.2 48.2 79.3 137.5 218.2 338.6 437.4 
Geographical area                               
  Galicia 72 120.7 99.0 - 147.2 169.1 147.7 - 190.5 47.8 79.0 125.3 196.5 306.5 493.4 
  Asturias, Cantabria 50 189.3 132.3 - 270.8 243.1 158.5 - 327.7 64.7 103.0 193.3 365.2 542.0 599.1 
  Basque Country 74 289.2 232.7 - 359.5 344.0 270.7 - 417.3 156.1 217.6 268.0 390.4 628.2 1029.6 
  Navarre, La Rioja, Aragon 67 122.1 114.6 - 130.1 152.9 129.9 - 175.9 47.3 90.8 137.4 188.2 259.0 350.5 
  Catalonia 125 168.8 113.2 - 251.7 242.7 80.8 - 404.7 71.4 101.7 156.1 241.7 443.3 576.1 
  Castile and Leon 76 95.9 70.1 - 131.3 138.9 97.6 - 180.3 24.0 59.9 107.3 164.6 345.8 449.0 
  Madrid 105 117.3 70.0 - 196.4 157.7 88.7 - 226.7 41.3 74.7 129.7 204.8 280.4 355.4 
  Castile-La Mancha, Extremadura 70 104.4 81.7 - 133.3 126.1 92.4 - 159.8 44.3 67.6 97.8 167.9 258.8 301.5 
  Valencian Community, Balearic Islands 96 145.0 112.0 - 187.8 183.7 149.0 - 218.4 52.2 98.8 163.9 263.4 356.2 381.1 
  Andalusia, Ceuta 118 97.5 67.2 - 141.3 144.0 77.0 - 211.0 22.6 64.0 114.7 175.6 247.4 342.0 
  Murcia 38 126.4 122.4 - 130.5 166.2 166.2 - 166.3 46.4 78.1 135.4 211.4 333.9 373.2 
  Canary Islands 26 78.8 70.3 - 88.3 89.5 78.5 - 100.5 32.4 59.3 83.8 105.3 171.7 182.6 
Quarter                               
  January - March 190 140.7 128.8 - 153.6 171.9 159.2 - 184.7 65.7 101.7 156.1 232.9 324.2 390.4 
  April - June 252 159.5 124.9 - 203.8 223.4 133.4 - 313.4 66.5 100.7 167.9 258.8 383.5 518.6 
  July - August 195 137.7 112.1 - 169.0 181.4 135.8 - 227.0 56.7 89.9 147.7 246.3 365.2 458.6 
  September - December 260 91.3 71.7 - 116.3 139.4 100.9 - 177.8 25.3 57.1 110.1 186.9 302.9 416.9 
Fish and shellfish consumption                               
  <Once per week 89 81.6 63.1 - 105.7 117.8 87.8 - 147.9 25.1 52.2 95.3 150.2 275.8 364.6 
  Once per week 252 114.6 101.8 - 128.9 150.9 134.6 - 167.2 44.3 72.1 116.4 189.7 305.5 381.1 
  2/4 times per week 445 147.4 128.9 - 168.6 202.3 164.8 - 239.9 55.3 93.5 156.8 237.1 358.4 444.3 
  ≥5 times per week 115 147.7 113.3 - 192.5 215.0 139.2 - 290.9 48.5 93.4 151.0 234.8 368.1 576.1 
BMI                                 
  Normal (<25) 809 132.5 115.6 - 151.7 186.0 151.1 - 220.9 48.2 80.5 140.3 220.9 345.8 443.3 
  Overweight (25-30) 71 106.5 89.1 - 127.3 147.2 110.9 - 183.5 36.2 66.2 100.7 167.1 338.6 391.3 
  Obesity (>30) 17 136.9 83.6 - 224.2 175.3 100.4 - 250.2 42.9 87.2 134.8 214.3 357.4 416.9 
 
Table 2c: PCBs levels for women according to age groups, economic activity sector, geographical area, sampling trimester, fish and shellfish consumption 
and Body Mass Index. Geometric mean (GM*) arithmetic mean (AM*) and their confidence intervals (95%) of the ΣPCB 138, 153 and 180 expressed in ng/g 
lipid, as well as percentiles 10, 25, 50, 75, 90 and 95.  
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 N GM 95% CI AM 95% CI 
Percentiles <LOQ 
P10 P25 P50 P75 P90 N % 95% CI 
PCB 138                    
Men 963 31.92 28.51 - 35.73 45.77 41.07 - 50.47 11.18 20.06 35.25 57.09 93.05 14 1.36 0.40 - 2.32 
Women 917 31.85 28.27 - 35.89 47.14 37.69 - 56.59 11.35 20.05 34.31 55.76 86.74 2 0.21 0.00 - 0.52 
PCB 153                    
Men 963 44.23 39.22 - 49.88 62.49 54.88 - 70.10 16.51 27.18 47.78 79.00 125.75 9 0.88 0.13 - 1.63 
Women 917 42.82 37.56 - 48.82 60.33 50.09 - 70.56 15.37 26.40 45.57 72.97 118.03 2 0.17 0.00 - 0.51 
PCB 180                    
Men 963 59.12 51.80 - 67.46 83.47 72.23 - 94.72 20.37 33.15 62.97 106.48 171.49 1 0.10 0.00 - 0.32 
Women 917 52.17 45.56 - 59.75 74.63 61.07 - 88.19 18.46 31.01 55.06 90.38 139.47 0 - -  - 
 
Table 3: Contribution of individual PCB congeners for both men and women. The geometric mean (GM), arithmetic mean (AM) and their confidence 
intervals (95%), percentiles 10, 25, 50, 75 and 90 of the PCB 138, 153 and 180 expressed in ng/g lipid, as well as the percentage of samples below Limit 
of Quantification (LOQ) . 
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TOTAL Men Women 
  exp(b) 
[95% 
Conf.Interval] P exp(b) 
[95% Conf. 
Interval] P exp(b) 
[95% Conf. 
Interval] P 
                          
Sex                         
Women 1                       
Men 1.09 1.02 1.15 0.01                 
Age*                         
≤29 years 0.50 0.47 0.53 0.00 0.47 0.41 0.52 0.00 0.56 0.50 0.62 0.00 
30-39 years 0.83 0.79 0.87 0.00 0.83 0.77 0.90 0.00 0.83 0.76 0.90 0.00 
40-49 years 1.31 1.24 1.39 0.00 1.29 1.19 1.40 0.00 1.37 1.26 1.49 0.00 
≥50 years 1.83 1.73 1.95 0.00 2.01 1.89 2.12 0.00 1.58 1.42 1.76 0.00 
Economic sector                         
Services 1       1       1       
Other sectors 0.89 0.79 1.00 0.05 0.88 0.77 1.01 0.07 0.96 0.77 1.20 0.70 
Geographical area*                         
Galicia 0.97 0.87 1.08 0.57 0.99 0.88 1.12 0.88 0.96 0.86 1.07 0.40 
Asturias, Cantabria 1.45 1.04 2.01 0.03 1.50 1.10 2.03 0.01 1.37 0.95 1.97 0.09 
Basque Country 1.88 1.47 2.41 0.00 1.91 1.58 2.29 0.00 1.86 1.33 2.59 0.00 
Navarre, La Rioja, Aragon 0.99 0.75 1.31 0.95 0.95 0.72 1.26 0.72 1.08 0.89 1.31 0.43 
Catalonia 1.18 0.90 1.56 0.22 1.19 0.94 1.52 0.15 1.17 0.85 1.61 0.31 
Castile and Leon 0.91 0.80 1.04 0.17 0.86 0.71 1.03 0.11 0.99 0.88 1.12 0.89 
Madrid 0.91 0.83 1.01 0.08 0.94 0.82 1.07 0.31 0.87 0.72 1.05 0.13 
Castile-La Mancha, Extremadura 0.92 0.83 1.01 0.09 0.95 0.85 1.06 0.34 0.83 0.70 0.98 0.03 
Valencian Community, Balearic Islands 1.04 0.90 1.21 0.56 0.99 0.78 1.26 0.94 1.11 1.00 1.23 0.05 
Andalusia, Ceuta 0.91 0.75 1.11 0.32 0.90 0.74 1.08 0.25 0.93 0.73 1.19 0.56 
Murcia 1.10 0.94 1.29 0.25 1.10 0.82 1.47 0.50 1.06 0.98 1.15 0.14 
Canary Islands 0.40 0.33 0.49 0.00 0.42 0.33 0.54 0.00 0.42 0.34 0.51 0.00 
Sampling quarter*                         
January - March 1.04 0.92 1.17 0.53 1.05 0.91 1.22 0.47 1.04 0.91 1.18 0.57 
April - June 1.23 1.10 1.38 0.00 1.21 1.07 1.38 0.00 1.25 1.10 1.42 0.00 
July - August 1.00 0.89 1.13 0.99 0.98 0.83 1.15 0.79 1.04 0.90 1.19 0.59 
September - December 0.78 0.73 0.84 0.00 0.80 0.72 0.89 0.00 0.74 0.67 0.82 0.00 
Frequency fish consumption                         
<1 per week 1       1       1       
1 per week 1.25 1.15 1.35 0.00 1.22 1.04 1.43 0.02 1.28 1.11 1.49 0.00 
2/4 per week 1.48 1.31 1.67 0.00 1.48 1.22 1.78 0.00 1.50 1.28 1.74 0.00 
≥5 per week 1.43 1.16 1.76 0.00 1.41 1.09 1.83 0.01 1.48 1.17 1.87 0.00 
 
* Reference: Geometric mean for all participants 
Table 4:  Multivariate analysis for the whole population and for men and women separately. Multivariate linear regression models were fitted 
using log-transfomed ∑PCBs levels as the dependent variable, and including  the following independent variables: age, sex (reference category 
was women), economic sector (reference category was services) fish and shellfish consumption (reference category was once per week), 
geographical area and sampling trimester. 
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N GM               (ng/g lipid) 
GM 
(ng/L)   






Spain (Our study) 2009-2010 16 - 65 1880 31.89 286.00 46.37  
Germany               
(GerESIII, Becker 2002) 1998 18 - 69 2823   420.00   
France                        
(ENNS, Fréry 2013) 2006 - 2007 18 - 74 386 70.80         457.40    
Czech Republic      
(Cerna 2008) 2006 > 18 202 186.00     
Slovakia                     
(Petrik et al., 2006)  2001 > 18 2047 138
+163: 165.00      
Italy (Esposito 2014) 2011-2012 18 - 64 58     36.88  
Greece               
(Leondiadis et al., 2004) 2002 - 2004   40     32.20  
United States                   
(NHANES, CDC, 2009) 
2001 - 2002 > 20 2293 138+158: 19.90      
2003 - 2004 > 20 1896 138+158: 15.10      
Canada (Health 2010) 2007 - 2009 20 - 79 1668 10.13                            60.00 15.11  
New Zealand            
(Bates 2004) 1996 - 1997 > 15 
60 
pools     138





Spain (Our study) 2009-2010 16 - 65 1880 43.61 377.00 61.54  
Germany               
(GerESIII, Becker 2002) 1998 18 - 69 2823   680.00   
France                        
(ENNS, Fréry 2013) 2006 - 2007 18 - 74 386 113.30          731.80   
Czech Republic       
(Cerna 2008) 2006 > 18 202 423.00     
Slovakia                     
(Petrik et al., 2006)  2001 > 18 2047 267.00     
Italy (Esposito 2014) 2011-2012 18 - 64 58     56.31  
Greece               
(Leondiadis et al., 2004) 2002 - 2004   40     
58.60  
United States                    
(NHANES, CDC, 2009) 
2001 - 2002 > 20 2306 27.20      
2003 - 2004 > 20 1896 19.80      
Canada (Health 2010) 2007 - 2009 20 - 79 1668 18.31                              110.00 28.62   
New Zealand            
(Bates 2004) 1996 - 1997 > 15 
60 





Spain (Our study) 2009-2010 16 - 65 1880 55.97                               490.00 79.60  
Germany               
(GerESIII, Becker 2002) 1998 18 - 69 2823   440.00   
France                        
(ENNS, Fréry 2013) 2006 - 2007 18 - 74 386 93.70      605.10    
Czech Republic       
(Cerna 2008) 2006 > 18 202 374.00     
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Slovakia                     
(Petrik et al., 2006)  2001 > 18 2047 246.00     
Italy (Esposito 2014) 2011-2012 18 - 64 58     72.81  
Greece               
(Leondiadis et al., 2004) 2002 - 2004   40     
58.30  
United States                  
(NHANES, CDC, 2009) 
2001 - 2002 > 20 2302 19.20     
2003 - 2004 > 20 1896 15.10      
Canada (Health 2010) 2007 - 2009 20 - 79 1668 15.21                 90.00 25.74  
New Zealand            
(Bates 2004) 1996 - 1997 > 15 
60 
pools     20.30     
 
 
Table 5: Serum levels of the main PCB contributors reported in different European countries compared to those found in 
our study in Spain.  The geometric mean  (GM) expressed in  ng/g lipid and in ng per L of serum  as well as  arithmetic 
mean (AM)  of PCB 138, 153 and 180.  
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Fish and shellfish consumption                                
Less than once per week Once per week 2/4 times per week More than 4 times per week
16-29 years 30-39 years 40-49 years 50-65 years
Figure 3
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Figure 1: Increase in ΣPCB 138,153,180 levels with the age. PCB levels increase by approximately 56% 
per 10 years of age, being higher in men than in women and with statistically significant 
differences (p<0.05) found in the oldest group (>50 years old). 
 
Figure 2: Ratio of the geometric means (GM) of the serum ΣPCB 138,153,180 concentrations for 
different geographical regions referred to the GM for all participants in Spain. The concentrations 
of ΣPCB congeners in samples from Northeast and Northern Spain were higher than those 
reported in the South. The lowest concentrations were found for the Canary Islands. 
 
Figure 3: Increase in serum ΣPCB 138,153,180  levels with frequency of weekly fish consumption and 
age. Bars represent the geometric mean of ∑PCB in each category, and lines represent 95% 
confidence interval.  
 
Figure legends
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